Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07815665 |
| Title | A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma (HARMONi-GU1) |
| Acronym | HARMONi-GU1 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Summit Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | NOT_YET_RECRUITING | Phoenix | Arizona | 85054 | United States | Details |
| Research Site | RECRUITING | Los Angeles | California | 90067 | United States | Details |
| Research Site | NOT_YET_RECRUITING | Washington D.C. | District of Columbia | 20010 | United States | Details |
| Research Site | NOT_YET_RECRUITING | Jacksonville | Florida | 32224 | United States | Details |
| Research Site | NOT_YET_RECRUITING | Rochester | Minnesota | 55905 | United States | Details |
| Research Site | NOT_YET_RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| Research Site | RECRUITING | Spokane | Washington | 99208 | United States | Details |